Immix... recnac latceroloc ni 011-XMI r-

Current Location: Home >Careers & Partnerships >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-06-06 14:08:33 Source: Author: Projects Views: 100

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: Events & Conferences)

[1]

[2]

[3]

Previous: Why... gnillaf era serahs onaN tibeeW
Next: ‘I... inu ot og nerdlihc rieht pleh